Yttrium-90 radioembolization as neoadjuvant therapy for potentially resectable patients with colorectal livel metastases: immune markers evaluation, impact on circulating tumor DNA and personalized dosimetry approach.
OBSERVATIONAL STUDY WITH MEDICINES
Clinical trial information
- Promoter: FERNANDO GOMEZ MUÑOZ
- Execution start: 27/10/2025
- End of execution: 30/10/2028
- IP: ANTONIO RODRIGUEZ FERNANDEZ
